COGNEX CORP - Quarter Report: 2013 June (Form 10-Q)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x | Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
for the quarterly period ended June 30, 2013
or
¨ | Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
for the transition period from to
Commission File Number 001-34218
COGNEX CORPORATION
(Exact name of registrant as specified in its charter)
Massachusetts | 04-2713778 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
One Vision Drive
Natick, Massachusetts 01760-2059
(508) 650-3000
(Address, including zip code, and telephone number, including area code, of principal executive offices)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act (Check one):
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x
As of June 30, 2013, there were 43,496,801 shares of Common Stock, $.002 par value per share, of the registrant outstanding.
Table of Contents
PART I | FINANCIAL INFORMATION |
|||||
Item 1. | Financial Statements (interim periods unaudited) |
|||||
3 | ||||||
4 | ||||||
Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012 |
5 | |||||
Consolidated Statement of Shareholders Equity for the six-month period ended June 30, 2013 |
6 | |||||
7 | ||||||
8 | ||||||
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
21 | ||||
Item 3. | 27 | |||||
Item 4. | 28 | |||||
PART II | 29 | |||||
Item 1. | 29 | |||||
Item 1A. | 30 | |||||
Item 2. | 30 | |||||
Item 3. | 31 | |||||
Item 4. | 31 | |||||
Item 5. | 31 | |||||
Item 6. | 31 | |||||
32 |
2
Table of Contents
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
Three-months Ended | Six-months Ended | |||||||||||||||
June 30, | July 1, | June 30, | July 1, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Revenue |
||||||||||||||||
Product |
$ | 79,698 | $ | 78,449 | $ | 154,370 | $ | 149,856 | ||||||||
Service |
6,812 | 5,877 | 13,032 | 12,179 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
86,510 | 84,326 | 167,402 | 162,035 | |||||||||||||
Cost of revenue |
||||||||||||||||
Product |
17,910 | 17,635 | 34,374 | 33,191 | ||||||||||||
Service |
3,240 | 2,914 | 6,199 | 6,416 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
21,150 | 20,549 | 40,573 | 39,607 | |||||||||||||
Gross margin |
||||||||||||||||
Product |
61,788 | 60,814 | 119,996 | 116,665 | ||||||||||||
Service |
3,572 | 2,963 | 6,833 | 5,763 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
65,360 | 63,777 | 126,829 | 122,428 | |||||||||||||
Research, development, and engineering expenses |
11,887 | 10,300 | 23,208 | 20,661 | ||||||||||||
Selling, general, and administrative expenses |
33,300 | 30,127 | 65,467 | 60,676 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating income |
20,173 | 23,350 | 38,154 | 41,091 | ||||||||||||
Foreign currency gain (loss) |
76 | (30 | ) | 139 | (668 | ) | ||||||||||
Investment income |
774 | 1,801 | 1,166 | 2,773 | ||||||||||||
Other expense |
(257 | ) | (99 | ) | (140 | ) | (96 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Income before income tax expense |
20,766 | 25,022 | 39,319 | 43,100 | ||||||||||||
Income tax expense |
3,946 | 5,255 | 6,916 | 9,051 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net income |
$ | 16,820 | $ | 19,767 | $ | 32,403 | $ | 34,049 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Earnings per weighted-average common and common-equivalent share: |
||||||||||||||||
Basic |
$ | 0.39 | $ | 0.46 | $ | 0.75 | $ | 0.80 | ||||||||
Diluted |
$ | 0.38 | $ | 0.45 | $ | 0.73 | $ | 0.78 | ||||||||
Weighted-average common and common-equivalent shares outstanding: |
||||||||||||||||
Basic |
43,522 | 42,851 | 43,392 | 42,710 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Diluted |
44,357 | 43,601 | 44,251 | 43,599 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Cash dividends per common share |
$ | 0.00 | $ | 0.11 | $ | 0.00 | $ | 0.21 | ||||||||
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
3
Table of Contents
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
Three-months Ended | Six-months Ended | |||||||||||||||
June 30, | July 1, | June 30, | July 1, | |||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Net income |
$ | 16,820 | $ | 19,767 | $ | 32,403 | $ | 34,049 | ||||||||
Other comprehensive loss, net of tax: |
||||||||||||||||
Net unrealized gain (loss) on available-for-sale investments, net of tax of ($318) and ($91) in the three-month periods and net of tax of ($276) and $200 in the six-month periods, respectively |
(1,279 | ) | 304 | (1,106 | ) | 1,618 | ||||||||||
Foreign currency translation adjustments, net of tax of $46 and ($403) in the three-month periods and net of tax of ($181) and ($197) in the six-month periods, respectively |
687 | (14,507 | ) | (1,807 | ) | (9,181 | ) | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive loss |
(592 | ) | (14,203 | ) | (2,913 | ) | (7,563 | ) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive income |
$ | 16,228 | $ | 5,564 | $ | 29,490 | $ | 26,486 | ||||||||
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
4
Table of Contents
CONSOLIDATED BALANCE SHEETS
(In thousands)
June 30, | December 31, | |||||||
2013 | 2012 | |||||||
(unaudited) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
47,874 | $ | 45,160 | |||||
Short-term investments |
135,289 | 105,105 | ||||||
Accounts receivable, less reserves of $1,134 and $1,131 in 2013 and 2012, respectively |
45,215 | 42,387 | ||||||
Inventories |
26,653 | 26,182 | ||||||
Deferred income taxes |
6,371 | 6,369 | ||||||
Prepaid expenses and other current assets |
15,777 | 14,394 | ||||||
|
|
|
|
|||||
Total current assets |
277,179 | 239,597 | ||||||
Long-term investments |
243,108 | 238,255 | ||||||
Property, plant, and equipment, net |
35,343 | 34,820 | ||||||
Deferred income taxes |
17,820 | 15,647 | ||||||
Intangible assets, net |
12,849 | 14,770 | ||||||
Goodwill |
81,689 | 81,689 | ||||||
Other assets |
2,388 | 2,827 | ||||||
|
|
|
|
|||||
$ | 670,376 | $ | 627,605 | |||||
|
|
|
|
|||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 7,157 | $ | 6,815 | ||||
Accrued expenses |
28,279 | 29,590 | ||||||
Accrued income taxes |
208 | 1,009 | ||||||
Deferred revenue and customer deposits |
13,479 | 12,690 | ||||||
|
|
|
|
|||||
Total current liabilities |
49,123 | 50,104 | ||||||
Reserve for income taxes |
6,255 | 5,216 | ||||||
Commitments and contingencies (Note 8) |
||||||||
Shareholders equity: |
||||||||
Common stock, $.002 par value Authorized: 140,000 shares, issued: 43,497 and 43,055 shares in 2013 and 2012, respectively |
87 | 86 | ||||||
Additional paid-in capital |
190,444 | 165,248 | ||||||
Retained earnings |
456,978 | 436,466 | ||||||
Accumulated other comprehensive loss, net of tax |
(32,511 | ) | (29,515 | ) | ||||
|
|
|
|
|||||
Total shareholders equity |
614,998 | 572,285 | ||||||
|
|
|
|
|||||
$ | 670,376 | $ | 627,605 | |||||
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
5
Table of Contents
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY
(In thousands)
Common Stock | Additional Paid-in |
Retained | Accumulated Other Comprehensive |
Total Shareholders |
||||||||||||||||||||
Shares | Par Value | Capital | Earnings | Loss | Equity | |||||||||||||||||||
Balance as of December 31, 2012 |
43,055 | $ | 86 | $ | 165,248 | $ | 436,466 | $ | (29,515 | ) | $ | 572,285 | ||||||||||||
Issuance of common stock under stock option plans |
710 | 1 | 16,241 | | | 16,242 | ||||||||||||||||||
Repurchase of common stock |
(268 | ) | | | (11,891 | ) | | (11,891 | ) | |||||||||||||||
Stock-based compensation expense |
| | 6,079 | | | 6,079 | ||||||||||||||||||
Excess tax benefit from stock option exercises |
| | 2,773 | | | 2,773 | ||||||||||||||||||
Tax benefit for research and development credits as a result of stock option accounting |
| | 103 | | | 103 | ||||||||||||||||||
Net income |
| | | 32,403 | | 32,403 | ||||||||||||||||||
Net unrealized loss on available-for-sale investments, net of tax of $276 |
| | | | (1,106 | ) | (1,106 | ) | ||||||||||||||||
Reclassification of net realized gain on the sale of available-for-sale investments |
| | | | (83 | ) | (83 | ) | ||||||||||||||||
Foreign currency translation adjustment, net of tax of $181 |
| | | | (1,807 | ) | (1,807 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Balance as of June 30, 2013 (unaudited) |
43,497 | $ | 87 | $ | 190,444 | $ | 456,978 | $ | (32,511 | ) | $ | 614,998 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
6
Table of Contents
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
Six-months Ended | ||||||||
June 30, | July 1, | |||||||
2013 | 2012 | |||||||
(unaudited) | ||||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 32,403 | $ | 34,049 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Stock-based compensation expense |
6,079 | 5,303 | ||||||
Depreciation of property, plant, and equipment |
3,596 | 3,180 | ||||||
Amortization of intangible assets |
1,921 | 2,086 | ||||||
Amortization of discounts or premiums on investments |
1,443 | 3,582 | ||||||
Realized gain on sale of investments |
(83 | ) | (1,071 | ) | ||||
Tax effect of stock option exercises |
(2,773 | ) | (2,969 | ) | ||||
Change in deferred income taxes |
(1,748 | ) | (1,076 | ) | ||||
Unrealized loss on trading securities |
462 | | ||||||
Change in operating assets and liabilities |
(2,325 | ) | (2,912 | ) | ||||
|
|
|
|
|||||
Net cash provided by operating activities |
38,975 | 40,172 | ||||||
Cash flows from investing activities: |
||||||||
Purchases of investments |
(167,652 | ) | (109,104 | ) | ||||
Maturities and sales of investments |
129,329 | 242,952 | ||||||
Purchases of property, plant, and equipment |
(4,310 | ) | (5,304 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) investing activities |
(42,633 | ) | 128,544 | |||||
Cash flows from financing activities: |
||||||||
Issuance of common stock under stock option plans |
16,242 | 13,929 | ||||||
Repurchase of common stock |
(11,891 | ) | | |||||
Payment of dividends |
| (8,985 | ) | |||||
Tax effect of stock option exercises |
2,773 | 2,969 | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
7,124 | 7,913 | ||||||
Effect of foreign exchange rate changes on cash and cash equivalents |
(752 | ) | (8,740 | ) | ||||
|
|
|
|
|||||
Net change in cash and cash equivalents |
2,714 | 167,889 | ||||||
Cash and cash equivalents at beginning of period |
45,160 | 38,103 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 47,874 | $ | 205,992 | ||||
|
|
|
|
The accompanying notes are an integral part of these consolidated financial statements.
7
Table of Contents
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 1: Summary of Significant Accounting Policies
As permitted by the rules of the Securities and Exchange Commission applicable to Quarterly Reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles (GAAP). Reference should be made to the consolidated financial statements and related notes included in the Companys Annual Report on Form 10-K for the year ended December 31, 2012.
In the opinion of the management of Cognex Corporation (the Company), the accompanying consolidated unaudited financial statements contain all adjustments, consisting of normal, recurring adjustments and financial statement reclassifications necessary to present fairly the Companys financial position as of June 30, 2013, and the results of its operations for the three-month and six-month periods ended June 30, 2013 and July 1, 2012, and changes in shareholders equity, comprehensive income, and cash flows for the periods presented.
The results disclosed in the Consolidated Statements of Operations for the three-month and six-month periods ended June 30, 2013 are not necessarily indicative of the results to be expected for the full year.
NOTE 2: New Pronouncements
Accounting Standards Update (ASU) 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income
The amendments in ASU 2013-02 require companies to present information about amounts reclassified out of accumulated other comprehensive income (OCI) to net income, by component. The effect of significant reclassification adjustments being made out of accumulated OCI on the corresponding line items in net income must be presented when the item is reclassified in its entirety during one reporting period. While the new guidance in ASU 2013-12 changes the presentation of accumulated OCI, there are no changes to the components that are recognized in net income or OCI under current accounting guidance.
Amounts reclassified from accumulated other comprehensive income to investment income on the Consolidated Statements of Operations were realized gains of $52,000 and $83,000 during the three-month and six-month periods ended June 30, 2013, respectively, and realized gains of $977,000 and $1,071,000 during the three-month and six-month periods ended July 1, 2012, respectively.
Accounting Standards Update (ASU) 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists
The amendments in ASU 2013-11 require companies to present an unrecognized tax benefit, or a portion thereof, as a reduction to a deferred tax asset for a net operating loss (NOL) carryforward or a similar tax loss or tax credit carryforward, unless the uncertain tax position is not available to reduce, or would not be used to reduce, the NOL or carryforward under the tax law in the same jurisdiction; otherwise, the unrecognized tax benefit should be presented as a gross liability and should not net the unrecognized tax benefit with a deferred tax asset. As the Company does not currently have any NOL carryforwards, this guidance will most likely apply to research and development tax credit carryforwards. ASU 2013-11 is effective for annual periods beginning after December 15, 2013 and should be applied to all unrecognized tax benefits that exist as of the effective date. Companies may choose to apply this guidance retrospectively to each prior reporting period presented. Management is the process of evaluating the impact of this Update.
8
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
NOTE 3: Fair Value Measurements
Financial Assets and Liabilities that are Measured at Fair Value on a Recurring Basis
The following table summarizes the financial assets and liabilities required to be measured at fair value on a recurring basis as of June 30, 2013 (in thousands):
Quoted Prices in Active Markets for Identical Assets (Level 1) |
Significant
Other Observable Inputs (Level 2) |
|||||||
Assets: |
||||||||
Cash equivalents |
$ | 12,947 | $ | | ||||
Corporate stock |
1,669 | | ||||||
Money market instruments |
460 | | ||||||
Corporate bonds |
| 190,166 | ||||||
Asset-backed securities |
| 68,176 | ||||||
Treasury bills |
| 52,415 | ||||||
Sovereign bonds |
| 30,435 | ||||||
Municipal bonds |
| 28,583 | ||||||
Commercial paper |
| 3,000 | ||||||
Agency bonds |
| 1,498 | ||||||
Currency forward contracts |
| 61 | ||||||
Liabilities: |
||||||||
Currency forward contracts |
| 11 |
The Companys cash equivalents and money market instruments are reported at fair value based upon the daily market price for identical assets in active markets, and are therefore classified as Level 1 investments. The Companys corporate stock position is reported at fair value based upon quoted market prices on a stock exchange, and is therefore classified as a Level 1 investment.
The Companys debt securities and currency forward contracts are reported at fair value based upon model-driven valuations in which all significant inputs are observable or can be derived from or corroborated by observable market data for substantially the full term of the asset, and are therefore classified as Level 2 investments. Management is responsible for estimating the fair value of these financial assets and liabilities, and in doing so, considers valuations provided by a large, third-party pricing service. For debt securities, this service maintains regular contact with market makers, brokers, dealers, and analysts to gather information on market movement, direction, trends, and other specific data. They use this information to structure yield curves for various types of debt securities and arrive at the daily valuations.
The Company did not record an other-than-temporary impairment of these investments during the six-month period ended June 30, 2013.
Financial Assets that are Measured at Fair Value on a Non-recurring Basis
The Company has an interest in a limited partnership, which is accounted for using the cost method and is required to be measured at fair value on a non-recurring basis. Management is responsible for estimating the fair value of this investment, and in doing so, considers valuations of the partnerships investments as determined by the General Partner. Publicly-traded investments in active markets are reported at the market closing price less a discount, as appropriate, to reflect restricted marketability. Fair value for private investments for which observable market prices in active markets do not exist is based upon the best information available including the value of a recent financing, reference to observable valuation measures for comparable companies (such as revenue multiples), public or private transactions (such as the sale of a comparable company), and valuations for publicly-traded comparable companies. The valuations also
9
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
incorporate the General Partners own judgment and close familiarity with the business activities of each portfolio company. Significant increases or decreases in any of these inputs in isolation may result in a significantly lower or higher fair value measurement. The portfolio consists of securities of public and private companies, and consequently, inputs used in the fair value calculation are classified as Level 3. The Company did not record an other-than-temporary impairment of this asset during the six-month period ended June 30, 2013.
Non-financial Assets that are Measured at Fair Value on a Non-recurring Basis
Non-financial assets such as goodwill, intangible assets, and property, plant, and equipment are required to be measured at fair value only when an impairment loss is recognized. The Company did not record an impairment charge related to these assets during the six-month period ended June 30, 2013.
NOTE 4: Cash, Cash Equivalents, and Investments
Cash, cash equivalents, and investments consisted of the following (in thousands):
June 30, 2013 |
December 31, 2012 |
|||||||
Cash |
$ | 34,467 | $ | 34,986 | ||||
Cash equivalents |
12,947 | 5,098 | ||||||
Money market instruments |
460 | 5,076 | ||||||
|
|
|
|
|||||
Cash and cash equivalents |
47,874 | 45,160 | ||||||
|
|
|
|
|||||
Corporate bonds |
80,386 | 46,001 | ||||||
Asset-backed securities |
26,910 | 17,666 | ||||||
Municipal bonds |
14,443 | 16,224 | ||||||
Sovereign bonds |
7,383 | 3,986 | ||||||
Commercial paper |
3,000 | | ||||||
Corporate stock |
1,669 | 2,131 | ||||||
Agency bonds |
1,498 | 7,482 | ||||||
Covered bonds |
| 5,618 | ||||||
Treasury bills |
| 5,997 | ||||||
|
|
|
|
|||||
Short-term investments |
135,289 | 105,105 | ||||||
|
|
|
|
|||||
Corporate bonds |
109,780 | 100,072 | ||||||
Treasury bills |
52,415 | 36,276 | ||||||
Asset-backed securities |
41,266 | 34,710 | ||||||
Sovereign bonds |
23,052 | 10,606 | ||||||
Municipal bonds |
14,140 | 17,846 | ||||||
Agency bonds |
| 29,441 | ||||||
Covered bonds |
| 5,564 | ||||||
Limited partnership interest (accounted for using cost method) |
2,455 | 3,740 | ||||||
|
|
|
|
|||||
Long-term investments |
243,108 | 238,255 | ||||||
|
|
|
|
|||||
$ | 426,271 | $ | 388,520 | |||||
|
|
|
|
The Companys investment portfolio includes corporate bonds, asset-backed securities, treasury bills, sovereign bonds, municipal bonds, commercial paper, and agency bonds. Corporate bonds consist of debt securities issued by both domestic and foreign companies; asset-backed securities consist of debt securities collateralized by pools of receivables or loans with credit enhancement; treasury bills consist of debt securities issued by both the U.S. and foreign governments; sovereign bonds consist of direct debt issued by foreign governments; municipal bonds consist of debt securities issued by state and local government
10
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
entities; commercial paper consists of debt instruments issued by corporations or financial institutions with high quality debt ratings; and agency bonds consist of domestic or foreign obligations of government agencies and government sponsored enterprises that have government backing.
During the fourth quarter of 2012, the Company purchased equity securities, representing stock in a publicly-traded U.S. company, with an aggregate fair value of $2,131,000 as of December 31, 2012. As of June 30, 2013, these securities had an aggregate fair value of $1,669,000, resulting in an unrealized loss of $462,000.
The following tables summarize the Companys available-for-sale investments as of June 30, 2013 (in thousands):
Amortized Cost |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value | |||||||||||||
Short-term: |
||||||||||||||||
Corporate bonds |
$ | 80,547 | $ | 119 | $ | (280 | ) | $ | 80,386 | |||||||
Asset-backed securities |
27,076 | 6 | (172 | ) | 26,910 | |||||||||||
Municipal bonds |
14,416 | 28 | (1 | ) | 14,443 | |||||||||||
Sovereign bonds |
7,396 | | (13 | ) | 7,383 | |||||||||||
Commercial paper |
3,000 | | | 3,000 | ||||||||||||
Agency bonds |
1,498 | | | 1,498 | ||||||||||||
Long-term: |
||||||||||||||||
Corporate bonds |
109,785 | 373 | (378 | ) | 109,780 | |||||||||||
Treasury bills |
52,487 | | (72 | ) | 52,415 | |||||||||||
Asset-backed securities |
41,539 | 6 | (279 | ) | 41,266 | |||||||||||
Sovereign bonds |
23,199 | 17 | (164 | ) | 23,052 | |||||||||||
Municipal bonds |
14,110 | 62 | (32 | ) | 14,140 | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 375,053 | $ | 611 | $ | (1,391 | ) | $ | 374,273 | ||||||||
|
|
|
|
|
|
|
|
The following table summarizes the Companys gross unrealized losses and fair values for available-for-sale investments in an unrealized loss position as of June 30, 2013 (in thousands):
Unrealized Loss Position For: | ||||||||||||||||||||||||
Less than 12 Months | 12 Months or Greater | Total | ||||||||||||||||||||||
Fair Value | Unrealized Losses |
Fair Value | Unrealized Losses |
Fair Value | Unrealized Losses |
|||||||||||||||||||
Corporate bonds |
$ | 107,235 | $ | (658 | ) | $ | | $ | | $ | 107,235 | $ | (658 | ) | ||||||||||
Sovereign bonds |
23,007 | (177 | ) | | | 23,007 | (177 | ) | ||||||||||||||||
Municipal bonds |
5,846 | (33 | ) | | | 5,846 | (33 | ) | ||||||||||||||||
Asset-backed securities |
59,180 | (449 | ) | 1,570 | (2 | ) | 60,750 | (451 | ) | |||||||||||||||
Treasury bills |
50,617 | (72 | ) | | | 50,617 | (72 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | 245,885 | $ | (1,389 | ) | $ | 1,570 | $ | (2 | ) | $ | 247,455 | $ | (1,391 | ) | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of June 30, 2013, the Company did not recognize an other-than-temporary impairment of these investments. In its evaluation, management considered the type of security, the credit rating of the security, the length of time the security has been in a loss position, the size of the loss position, our intent and ability to hold the security to expected recovery of value, and other meaningful information. The Company does not intend to sell, and is unlikely to be required to sell, any of these available-for-sale investments before its effective maturity or market price recovery.
The Company recorded gross realized gains and gross realized losses on the sale of investments totaling $101,000 and $49,000, respectively, during the three-month period ended June 30, 2013, and $1,233,000 and $238,000, respectively, during the three-month period ended July 1, 2012. The Company recorded gross realized gains and gross realized losses on the sale of investments totaling $150,000 and $67,000, respectively, during the six-month period ended June 30, 2013, and $1,327,000 and $238,000, respectively, during the six-month period ended July 1, 2012.
11
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The following table presents the effective maturity dates of the Companys available-for-sale investments as of June 30, 2013 (in thousands):
<1 Year |
1-2 Years |
2-3 Years |
3-4 Years |
4-5 Years |
Total | |||||||||||||||||||
Corporate bonds |
$ | 80,386 | $ | 48,477 | $ | 54,059 | $ | 6,729 | $ | 515 | $ | 190,166 | ||||||||||||
Asset-backed securities |
26,910 | 35,072 | 6,194 | | | 68,176 | ||||||||||||||||||
Treasury bills |
| 29,870 | 22,545 | | | 52,415 | ||||||||||||||||||
Sovereign bonds |
7,383 | 11,263 | 10,907 | | 882 | 30,435 | ||||||||||||||||||
Municipal bonds |
14,443 | 8,817 | 2,337 | 2,491 | 495 | 28,583 | ||||||||||||||||||
Commercial paper |
3,000 | | | | | 3,000 | ||||||||||||||||||
Agency bonds |
1,498 | | | | | 1,498 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | 133,620 | $ | 133,499 | $ | 96,042 | $ | 9,220 | $ | 1,892 | $ | 374,273 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
The Company is a Limited Partner in Venrock Associates III, L.P. (Venrock), a venture capital fund. The Company has committed to a total investment in the limited partnership of up to $20,500,000, with an expiration date of December 31, 2013. As of June 30, 2013, the Company contributed $19,886,000 to the partnership. The remaining commitment of $614,000 can be called by Venrock at any time before December 31, 2013. Distributions and contributions are at the discretion of Venrocks management. No contributions were made during the six-month period ended June 30, 2013. The Company received a cash distribution of $1,285,000 during the second quarter of 2013, which was accounted for as a return of capital.
NOTE 5: Inventories
Inventories consisted of the following (in thousands):
June 30, 2013 |
December 31, 2012 |
|||||||
Raw materials |
$ | 12,837 | $ | 12,667 | ||||
Work-in-process |
3,947 | 4,193 | ||||||
Finished goods |
9,869 | 9,322 | ||||||
|
|
|
|
|||||
$ | 26,653 | $ | 26,182 | |||||
|
|
|
|
NOTE 6: Intangible Assets and Goodwill
The Company evaluates the possible impairment of goodwill and other intangible assets whenever events or circumstances indicate that the carrying value of these assets may not be recoverable. No triggering event occurred in the six-month period ended June 30, 2013 that would indicate a potential impairment of goodwill or other intangible assets. However, the Company continues to monitor a variety of factors that could result in an impairment of goodwill or other intangible assets in a future period.
NOTE 7: Warranty Obligations
The Company records the estimated cost of fulfilling product warranties at the time of sale based upon historical costs to fulfill claims. Obligations may also be recorded subsequent to the time of sale whenever specific events or circumstances impacting product quality become known that would not have been taken
12
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
into account using historical data. While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers and third-party contract manufacturers, the Companys warranty obligation is affected by product failure rates, material usage, and service delivery costs incurred in correcting a product failure. An adverse change in any of these factors may result in the need for additional warranty provisions. Warranty obligations are included in Accrued expenses on the Consolidated Balance Sheets.
The changes in the warranty obligations were as follows (in thousands):
Balance as of December 31, 2012 |
$ | 2,256 | ||
Provisions for warranties during the period |
1,265 | |||
Fulfillment of warranty obligations |
(990 | ) | ||
Foreign exchange rate changes |
(24 | ) | ||
|
|
|||
Balance as of June 30, 2013 |
$ | 2,507 | ||
|
|
NOTE 8: Contingencies
In May 2008, the Company filed a complaint against MvTec Software GmbH, MvTec LLC, and Fuji America Corporation in the United States District Court for the District of Massachusetts alleging infringement of certain patents owned by the Company. In April 2009 and again in June 2009, Defendant MvTec Software GmbH filed re-examination requests of the patents-at-issue with the United States Patent and Trademark Office. This matter is ongoing.
In May 2009, the Company pre-filed a complaint with the United States International Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. §1337, against MvTec Software GmbH, MvTec LLC, Fuji America, and several other respondents alleging unfair methods of competition and unfair acts in the unlawful importation into the United States, sale for importation, or sale within the United States after importation. By this filing, the Company requested the ITC to investigate the Companys contention that certain machine vision software, machine vision systems, and products containing the same infringe, and respondents directly infringe and/or actively induce and/or contribute to the infringement in the United States, of one or more of the Companys U.S. patents. In July 2009, the ITC issued an order that it would institute an investigation based upon the Companys assertions. In September 2009, the Company reached a settlement with two of the respondents, and in December 2009, the Company reached a settlement with five additional respondents. In March 2010, the Company reached a settlement with respondent Fuji Machine Manufacturing Co., Ltd. and its subsidiary Fuji America Corporation. These settlements did not have a material impact on the Companys financial results. An ITC hearing was held in May 2010. In July 2010, the Administrative Law Judge issued an initial determination finding two of the Companys patents invalid and that respondents did not infringe the patents-at-issue. In September 2010, the ITC issued a notice that it would review the initial determination of the Administrative Law Judge. The ITC issued its Final Determination in November 2010 in which it determined to modify-in-part and affirm-in-part the Administrative Law Judges determination, and terminate the investigation with a finding of no violation of Section 337 of the Tariff Act of 1930 (as amended 19 U.S.C. §1337). The Company has filed an appeal of the decision with the United States Court of Appeals for the Federal Circuit. An oral hearing before the United States Court of Appeals occurred in February 2012. This matter is ongoing.
In March 2013, the Company filed a lawsuit against Microscan Systems, Inc. (Microscan) and Code Corporation in the United States District Court for the Southern District of New York alleging that Microscans Mobile Hawk handheld imager infringes U.S. Patent 7,874,487 owned by the Company. The lawsuit seeks to prohibit Code Corporation from manufacturing the product, and Microscan from selling and distributing the product. The Company is also seeking monetary damages resulting from the alleged infringement. In April 2013, Microscan filed ex parte re-examination requests of the patent-at-issue with the United States Patent and Trademark Office. These matters are ongoing.
13
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The Company cannot predict the outcome of the above-referenced pending matters and an adverse resolution of these lawsuits could have a material adverse effect on the Companys financial position, liquidity, results of operations, and/or indemnification obligations. In addition, various other claims and legal proceedings generally incidental to the normal course of business are pending or threatened on behalf of or against the Company. While we cannot predict the outcome of these incidental matters, we believe that any liability arising from them will not have a material adverse effect on our financial position, liquidity, or results of operations.
NOTE 9: Indemnification Provisions
Except as limited by Massachusetts law, the by-laws of the Company require it to indemnify certain current or former directors, officers, and employees of the Company against expenses incurred by them in connection with each proceeding in which he or she is involved as a result of serving or having served in certain capacities. Indemnification is not available with respect to a proceeding as to which it has been adjudicated that the person did not act in good faith in the reasonable belief that the action was in the best interests of the Company. The maximum potential amount of future payments the Company could be required to make under these provisions is unlimited. The Company has never incurred significant costs related to these indemnification provisions. As a result, the Company believes the estimated fair value of these provisions is minimal.
In the ordinary course of business, the Company may accept standard limited indemnification provisions in connection with the sale of its products, whereby it indemnifies its customers for certain direct damages incurred in connection with third-party patent or other intellectual property infringement claims with respect to the use of the Companys products. The term of these indemnification provisions generally coincides with the customers use of the Companys products. The maximum potential amount of future payments the Company could be required to make under these provisions is generally subject to fixed monetary limits. The Company has never incurred significant costs to defend lawsuits or settle claims related to these indemnification provisions. As a result, the Company believes the estimated fair value of these provisions is minimal.
In the ordinary course of business, the Company also accepts limited indemnification provisions from time to time, whereby it indemnifies customers for certain direct damages incurred in connection with bodily injury and property damage arising from the installation of the Companys products. The term of these indemnification provisions generally coincides with the period of installation. The maximum potential amount of future payments the Company could be required to make under these provisions is generally limited and is likely recoverable under the Companys insurance policies. As a result of this coverage, and the fact that the Company has never incurred significant costs to defend lawsuits or settle claims related to these indemnification provisions, the Company believes the estimated fair value of these provisions is minimal.
NOTE 10: Derivative Instruments
The Company is exposed to certain risks relating to its ongoing business operations including foreign currency exchange rate risk and interest rate risk. The Company currently mitigates certain foreign currency exchange rate risks with derivative instruments. The Company does not currently manage its interest rate risk with derivative instruments.
The Company faces exposure to foreign currency exchange rate fluctuations, as a significant portion of its revenues, expenses, assets, and liabilities are denominated in currencies other than the functional currencies of the Companys subsidiaries or the reporting currency of the Company, which is the U.S. Dollar. The Company faces two types of foreign currency exchange rate exposures:
| Transactional currency/functional currency exchange rate exposures from transactions that are denominated in currencies other than the functional currency of the subsidiary. These transactions gains and losses are reported on the Consolidated Statements of Operations as a component of Foreign Currency Gain (Loss), |
| Functional currency/reporting currency exchange rate exposures from the revaluation of the assets and liabilities of our foreign subsidiaries, whose functional currency is generally their local currency, to the Companys reporting currency, which is the U.S. Dollar. The net effect of these translation gains and losses are reported in Accumulated Other Comprehensive Loss on the Consolidated Balance Sheets, and also on the Consolidated Statements of Comprehensive Income. |
14
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The Companys foreign currency risk management strategy is principally designed to mitigate the potential financial impact of changes in the value of transactions and balances denominated in foreign currencies resulting from changes in foreign currency exchange rates. Derivative instruments, specifically foreign currency forward contracts with maturities of up to three months, are used to manage the exposure to fluctuations in foreign currency exchange rates that arise primarily from foreign-denominated receivables and payables. As of June 30, 2013, the Companys forward contracts do not qualify for effective hedge accounting. Because forward contracts are used as an economic hedge, any gain or loss on the underlying foreign-denominated balance is intended to be offset by the loss or gain on the forward contract. Gains and losses on forward contracts and foreign-denominated receivables and payables are included in Foreign Currency Gain (Loss) on the Consolidated Statements of Operations. The Company recorded net foreign currency gains of $76,000 and $139,000 in the three-month and six-month periods ended June 30, 2013, respectively, and net foreign currency losses of $30,000 and $668,000 in the three-month and six-month periods ended July 1, 2012, respectively.
As of June 30, 2013, the Company had the following outstanding forward contracts that were entered into to mitigate foreign currency exchange rate risk (in thousands):
Currency |
Notional Value |
USD Equivalent |
||||||
Japanese Yen |
316,600 | $ | 3,214 | |||||
Korean Won |
275,000 | 240 | ||||||
Hungarian Forint |
99,500 | 436 | ||||||
Taiwanese Dollar |
27,500 | 920 | ||||||
Swedish Krona |
5,700 | 848 | ||||||
Singapore Dollar |
2,500 | 1,968 | ||||||
British Pound |
425 | 654 |
Information regarding the fair value of the forward contracts outstanding as of June 30, 2013 and December 31, 2012 was as follows (in thousands):
Asset Derivatives | Liability Derivatives | |||||||||||||||||||
Fair Value | Fair Value | |||||||||||||||||||
Balance Sheet Location |
June 30, 2013 |
December 31, 2012 |
Balance Sheet Location |
June 30, 2013 |
December 31, 2012 |
|||||||||||||||
Foreign currency forward contracts |
Prepaid expenses and other current assets |
$ | 61 | $ | 44 | Accrued expenses |
$ | 11 | $ | 14 |
15
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Information regarding the effect of the forward contracts, net of the underlying exposure, on the Consolidated Statements of Operations for the three-month and six-month periods ended June 30, 2013 and July 1, 2012 was as follows (in thousands):
Amount of Gain Recognized |
Amount of Gain
(Loss) Recognized |
|||||||||||||||||||
Three-months ended | Six-months ended | |||||||||||||||||||
Location of Gain Recognized |
June 30, 2013 |
July 1, 2012 |
Location of
Gain (Loss) |
June 30, 2013 |
July 1, 2012 |
|||||||||||||||
Foreign currency forward contracts |
Foreign currency gain |
$ | 64 | $ | 198 | Foreign currency gain (loss) |
$ | 197 | $ | (91 | ) |
NOTE 11: Stock-Based Compensation Expense
The Companys share-based payments that result in compensation expense consist solely of stock option grants. As of June 30, 2013, the Company had 5,614,591 shares available for grant under two stock option plans: the 2001 General Stock Option Plan (4,355,481) and the 2007 Stock Option and Incentive Plan (1,259,110). Each of these plans expires ten years from the date the plan was approved. In December 2011, the 2001 General Stock Option Plan received shareholder approval for an amendment and restatement of the plan, extending the plan until September 2021. Generally, stock options are granted with an exercise price equal to the market value of the Companys common stock at the grant date, vest over four years based upon continuous service, and expire ten years from the grant date.
The following table summarizes the Companys stock option activity for the six-month period ended June 30, 2013:
Shares (in thousands) |
Weighted- Average Exercise Price |
Weighted- Average Remaining Contractual Term (in years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Outstanding as of December 31, 2012 |
3,559 | $ | 25.56 | |||||||||||||
Granted |
823 | 42.12 | ||||||||||||||
Exercised |
(710 | ) | 22.88 | |||||||||||||
Forfeited or expired |
(122 | ) | 32.53 | |||||||||||||
|
|
|||||||||||||||
Outstanding as of June 30, 2013 |
3,550 | $ | 29.70 | 7.4 | $ | 55,132 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Exercisable as of June 30, 2013 |
1,309 | $ | 23.03 | 5.8 | $ | 29,075 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Options vested or expected to vest at June 30, 2013 (1) |
3,139 | $ | 28.93 | 7.3 | $ | 51,172 | ||||||||||
|
|
|
|
|
|
|
|
(1) | In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. Options expected to vest are calculated by applying an estimated forfeiture rate to the unvested options. |
16
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The fair values of stock options granted in each period presented were estimated using the following weighted-average assumptions:
Three-months Ended | Six-months Ended | |||||||||||||||
June 30, 2013 |
July 1, 2012 |
June 30, 2013 |
July 1, 2012 |
|||||||||||||
Risk-free rate |
2.0 | % | 2.0 | % | 2.0 | % | 2.0 | % | ||||||||
Expected dividend yield |
0 | % | 1.2 | % | 0 | % | 1.2 | % | ||||||||
Expected volatility |
42 | % | 44 | % | 42 | % | 44 | % | ||||||||
Expected term (in years) |
5.9 | 5.7 | 5.9 | 5.7 |
Risk-free rate
The risk-free rate was based upon a treasury instrument whose term was consistent with the contractual term of the option.
Expected dividend yield
Generally, the current dividend yield is calculated by annualizing the cash dividend declared by the Companys Board of Directors and dividing that result by the closing stock price on the grant date. However, in the fourth quarter of 2012, the Company paid the full annual dividends for 2013 and 2014 in advance, and therefore, the dividend yield for those years has been adjusted to zero. At the time of the 2013 valuation, a dividend yield of 1.04% was estimated for future periods from 2015 through the expected life of the option.
Expected volatility
The expected volatility was based upon a combination of historical volatility of the Companys common stock over the contractual term of the option and implied volatility for traded options of the Companys stock.
Expected term
The expected term was derived from the binomial lattice model from the impact of events that trigger exercises over time.
The weighted-average grant-date fair values of stock options granted during the three-month periods ended June 30, 2013 and July 1, 2012 were $16.13 and $13.50, respectively. The weighted-average grant-date fair values of stock options granted during the six-month periods ended June 30, 2013 and July 1, 2012 were $16.13 and $13.35, respectively.
The Company stratifies its employee population into two groups: one consisting of senior management and another consisting of all other employees. The Company currently expects that approximately 71% of its stock options granted to senior management and 69% of its options granted to all other employees will actually vest. Therefore, the Company currently applies an estimated forfeiture rate of 12% to all unvested options for senior management and a rate of 13% for all other employees.
The total stock-based compensation expense and the related income tax benefit recognized for the three-month period ended June 30, 2013 were $2,781,000 and $911,000, respectively, and for the three-month period ended July 1, 2012 were $1,989,000 and $646,000, respectively. The total stock-based compensation expense and the related income tax benefit recognized for the six-month period ended June 30, 2013 were $6,079,000 and $2,004,000, respectively, and for the six-month period ended July 1, 2012 were $5,303,000 and $1,733,000, respectively. No compensation expense was capitalized as of June 30, 2013 or December 31, 2012.
The following table details the stock-based compensation expense by caption for each period presented on the Consolidated Statements of Operations (in thousands):
Three-months Ended | Six-months Ended | |||||||||||||||
June 30, 2013 |
July 1, 2012 |
June 30, 2013 |
July 1, 2012 |
|||||||||||||
Product cost of revenue |
$ | 177 | $ | 135 | $ | 404 | $ | 375 | ||||||||
Service cost of revenue |
47 | 40 | 110 | 108 | ||||||||||||
Research, development, and engineering |
650 | 483 | 1,463 | 1,350 | ||||||||||||
Selling, general, and administrative |
1,907 | 1,331 | 4,102 | 3,470 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 2,781 | $ | 1,989 | $ | 6,079 | $ | 5,303 | |||||||||
|
|
|
|
|
|
|
|
17
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The total intrinsic values of stock options exercised for the three-month periods ended June 30, 2013 and July 1, 2012 were $6,759,000 and $672,000, respectively. The total intrinsic values of stock options exercised for the six-month periods ended June 30, 2013 and July 1, 2012 were $13,952,000 and $13,308,000, respectively. The total fair values of stock options vested for the three-month periods ended June 30, 2013 and July 1, 2012 were $2,298,000 and $2,286,000, respectively. The total fair values of stock options vested for the six-month periods ended June 30, 2013 and July 1, 2012 were $9,230,000 and $8,686,000, respectively.
As of June 30, 2013, total unrecognized compensation expense related to non-vested stock options was $12,233,000, which is expected to be recognized over a weighted-average period of 1.6 years.
NOTE 12: Stock Repurchase Program
In April 2008, the Companys Board of Directors authorized the repurchase of up to $50,000,000 of the Companys common stock, primarily as a means to reduce the dilutive effect of employee stock options. As of June 30, 2013, the Company had repurchased a total of 1,643,875 shares at a cost of $41,891,000 under this program, including 268,000 shares at a cost of $11,891,000 in the second quarter of 2013. In November 2011, the Companys Board of Directors authorized the repurchase of up to $80,000,000 of the Companys common stock to help reduce share dilution associated with equity incentive plans. This new authorization will commence once the Company completes the $50,000,000 program noted above, of which $8,109,000 remains available. The Company may repurchase shares under these programs in future periods depending upon a variety of factors, including, among other things, stock price, share availability, and cash requirements.
NOTE 13: Taxes
A reconciliation of the United States federal statutory corporate tax rate to the Companys effective tax rate, or income tax provision, was as follows:
Three-months Ended | Six-months Ended | |||||||||||||||
June 30, 2013 |
July 1, 2012 |
June 30, 2013 |
July 1, 2012 |
|||||||||||||
Income tax at federal statutory rate |
35 | % | 35 | % | 35 | % | 35 | % | ||||||||
State income taxes, net of federal benefit |
2 | 1 | 2 | 1 | ||||||||||||
Foreign tax rate differential |
(17 | ) | (15 | ) | (17 | ) | (15 | ) | ||||||||
2013 research and development credit |
(1 | ) | | (1 | ) | | ||||||||||
Discrete event - 2012 research and development credit |
| | (1 | ) | | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income tax provision |
19 | % | 21 | % | 18 | % | 21 | % | ||||||||
|
|
|
|
|
|
|
|
During the six-month period ended June 30, 2013, the Company recorded a $918,000 increase in liabilities, net of deferred tax benefit, for uncertain tax positions that were recorded as income tax expense, of which $274,000 was recorded in the three-month period ended June 30, 2013. Estimated interest and penalties included in these amounts totaled $76,000 for the six-month period ended June 30, 2013, of which $38,000 was recorded in the three-month period ended June 30, 2013.
The effective tax rate for the six-month period ended June 30, 2013 includes a discrete event recorded in the first quarter of 2013 for the retroactive application of the 2012 research and development credit. The American Taxpayer Relief Act of 2012 was passed by Congress and signed into law on January 1, 2013. The provisions under this law are to be applied retroactively to January 1, 2012. As a result of the law being signed on January 1, 2013, the financial impact of the retroactive provision was recorded as a discrete event in the first quarter of 2013. The Company recorded a reduction to tax expense in the first quarter of 2013 of $555,000, net of related reserves for uncertain tax positions, for the aforementioned research and development tax credit. Excluding this discrete event, the effective tax rate for the six-month period ended June 30, 2013 was 19%. There were no discrete events in the three-month period ended June 30, 2013 or in the six-month period ended July 1, 2012.
18
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The Companys reserve for income taxes, including gross interest and penalties, was $6,255,000 as of June 30, 2013, all of which was classified as noncurrent. The amount of gross interest and penalties included in these balances was $1,303,000. If the Companys tax positions were sustained or the statutes of limitations related to certain positions expired, these reserves would be released and income tax expense would be reduced in a future period, less $405,000 that would be recorded through additional paid in capital. As a result of the expiration of certain statutes of limitations, there is a potential that a portion of these reserves could be released, which would decrease income tax expense by approximately $1,600,000 to $1,800,000 over the next twelve months.
The Company has defined its major tax jurisdictions as the United States, Ireland, China, and Japan, and within the United States, Massachusetts and California. Within the United States, the tax years 2006 through 2012 remain open to examination by various taxing authorities due to a 2009 carryback claim, while the tax years 2008 through 2012 remain open to examination by various taxing authorities in other jurisdictions in which the Company operates. The Company has recently been notified by the Internal Revenue Service that its U.S. Federal tax returns for years 2010 and 2011 are under audit. The Company believes it is adequately reserved for these years.
NOTE 14: Weighted-Average Shares
Weighted-average shares were calculated as follows (in thousands):
Three-months Ended | Six-months Ended | |||||||||||||||
June 30, 2013 |
July 1, 2012 |
June 30, 2013 |
July 1, 2012 |
|||||||||||||
Basic weighted-average common shares outstanding |
43,522 | 42,851 | 43,392 | 42,710 | ||||||||||||
Effect of dilutive stock options |
835 | 750 | 859 | 889 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted-average common and common-equivalent shares outstanding |
44,357 | 43,601 | 44,251 | 43,599 | ||||||||||||
|
|
|
|
|
|
|
|
Stock options to purchase 819,407 and 634,643 shares of common stock, on a weighted-average basis, were outstanding during the three-month and six-month periods ended June 30, 2013, respectively, and 931,839 and 872,237 for the same periods in 2012, but were not included in the calculation of dilutive net income per share because they were anti-dilutive.
NOTE 15: Segment Information
The Company has two reportable segments: the Modular Vision Systems Division (MVSD) and the Surface Inspection Systems Division (SISD). MVSD develops, manufactures, and markets modular vision systems that are used to control the manufacture of discrete items by locating, identifying, inspecting, and measuring them during the manufacturing process. SISD develops, manufactures, and markets surface inspection vision systems that are used to inspect surfaces of materials processed in a continuous fashion, such as metals, paper, nonwoven, plastics, and glass, to ensure there are no flaws or defects on the surfaces. Segments are determined based upon the way that management organizes its business for making operating decisions and assessing performance. The Company evaluates segment performance based upon income or loss from operations, excluding stock-based compensation expense.
19
Table of Contents
COGNEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
The following table summarizes information about the segments (in thousands):
Three-months Ended June 30, 2013 | MVSD | SISD | Reconciling Items |
Consolidated | ||||||||||||
Product revenue |
$ | 72,012 | $ | 7,686 | $ | | $ | 79,698 | ||||||||
Service revenue |
2,301 | 4,511 | | 6,812 | ||||||||||||
Operating income |
23,527 | 2,227 | (5,581 | ) | 20,173 |
Six-months Ended June 30, 2013 | MVSD | SISD | Reconciling Items |
Consolidated | ||||||||||||
Product revenue |
$ | 140,331 | $ | 14,039 | $ | | $ | 154,370 | ||||||||
Service revenue |
4,393 | 8,639 | | 13,032 | ||||||||||||
Operating income |
45,603 | 3,959 | (11,408 | ) | 38,154 |
Three-months Ended July 1, 2012 | MVSD | SISD | Reconciling Items |
Consolidated | ||||||||||||
Product revenue |
$ | 69,743 | $ | 8,706 | $ | | $ | 78,449 | ||||||||
Service revenue |
1,778 | 4,099 | | 5,877 | ||||||||||||
Operating income |
25,035 | 2,848 | (4,533 | ) | 23,350 |
Six-months Ended July 1, 2012 | MVSD | SISD | Reconciling Items |
Consolidated | ||||||||||||
Product revenue |
$ | 133,964 | $ | 15,892 | $ | | $ | 149,856 | ||||||||
Service revenue |
3,698 | 8,481 | | 12,179 | ||||||||||||
Operating income |
46,179 | 5,240 | (10,328 | ) | 41,091 |
Reconciling items consist of stock-based compensation expense and unallocated corporate expenses, which primarily include corporate headquarters costs, professional fees, and patent infringement litigation. Additional asset information by segment is not produced internally for use by the chief operating decision maker, and therefore, is not presented. Additional asset information is not provided because cash and investments are commingled and the segments share assets and resources in a number of locations around the world.
NOTE 16: Subsequent Event
On July 29, 2013 the Companys Board of Directors declared a two-for-one split of its common stock. The split will be effected in the form of a stock dividend, payable on September 16, 2013 to shareholders of record on August 26, 2013.
20
Table of Contents
ITEM 2: MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
Certain statements made in this report, as well as oral statements made by the Company from time to time, constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Readers can identify these forward-looking statements by our use of the words expects, anticipates, estimates, believes, projects, intends, plans, will, may, shall, could, should, and similar words and other statements of a similar sense. These statements are based upon our current estimates and expectations as to prospective events and circumstances, which may or may not be in our control and as to which there can be no firm assurances given. These forward-looking statements, which include statements regarding business and market trends, future financial performance, customer order rates, expected areas of growth, future product mix, research and development activities, and strategic plans, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) current and future conditions in the global economy; (2) the cyclicality of the semiconductor and electronics industries; (3) the reliance on revenue from the automotive industry; (4) the inability to penetrate new markets; (5) the inability to achieve significant international revenue; (6) fluctuations in foreign currency exchange rates; (7) the loss of a large customer; (8) the inability to attract and retain skilled employees; (9) the reliance upon key suppliers to manufacture and deliver critical components for our products; (10) the failure to effectively manage product transitions or accurately forecast customer demand; (11) the inability to design and manufacture high-quality products; (12) the technological obsolescence of current products and the inability to develop new products; (13) the failure to properly manage the distribution of products and services; (14) the inability to protect our proprietary technology and intellectual property; (15) our involvement in time-consuming and costly litigation; (16) the impact of competitive pressures; (17) the challenges in integrating and achieving expected results from acquired businesses; (18) potential impairment charges with respect to our investments or for acquired intangible assets or goodwill; (19) exposure to additional tax liabilities; and (20) information security breaches or business system disruptions. The foregoing list should not be construed as exhaustive and we encourage readers to refer to the detailed discussion of risk factors included in Part I Item 1A of the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2012. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. The Company disclaims any obligation to subsequently revise forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date such statements are made.
Executive Overview
Cognex Corporation is a leading worldwide provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. Our Modular Vision Systems Division (MVSD) specializes in machine vision systems that are used to automate the manufacture of discrete items, while our Surface Inspection Systems Division (SISD) specializes in machine vision systems that are used to inspect the surfaces of materials processed in a continuous fashion.
In addition to product revenue derived from the sale of machine vision systems, the Company also generates revenue by providing maintenance and support, training, consulting, and installation services to its customers. Our customers can be classified into three primary markets: factory automation, semiconductor and electronics capital equipment, and surface inspection.
| Factory automation customers, who are included in the Companys MVSD segment, purchase Cognex vision products and incorporate them into their manufacturing processes. Virtually every manufacturer can achieve better quality and manufacturing efficiency by using machine vision, and therefore, this market includes a broad base of customers across a variety of industries, including automotive, consumer electronics, food and beverage, pharmaceutical, and medical devices. The factory automation market also includes customers who purchase Cognex vision products for use outside of the assembly process, such as using ID products in logistics automation for package sorting and distribution. Sales to factory automation customers represented 78% of total revenue in the second quarter of 2013. |
21
Table of Contents
| Semiconductor and electronics capital equipment manufacturers, who are included in the Companys MVSD segment, purchase Cognex vision products and integrate them into the automation equipment that they manufacture and then sell to their customers to either make semiconductor chips or assemble printed circuit boards. Demand from these capital equipment manufacturers has historically been highly cyclical, with periods of investment followed by downturn. Sales to semiconductor and electronics capital equipment manufacturers represented 8% of total revenue in the second quarter of 2013. |
| Surface inspection customers, who comprise the Companys SISD segment, are manufacturers of materials processed in a continuous fashion, such as metals, paper, nonwoven, plastics, and glass. These customers need sophisticated machine vision to detect, classify, and analyze defects on the surfaces of those materials as they are being processed at high speeds. Surface inspection sales represented 14% of total revenue in the second quarter of 2013. |
Revenue for the second quarter of 2013 totaled $86,510,000, representing an increase of $2,184,000, or 3%, from the same period in the prior year driven by higher sales to customers in the factory automation market. Gross margin was 76% of revenue in both the second quarters of 2013 and 2012. Operating expenses increased by $4,760,000, or 12%, from the second quarter of 2012 due primarily to expenses associated with increased engineering and sales headcount in strategic areas, higher company bonus accruals, and higher stock-based compensation expense. As a result of these strategic investments, which management believes will fuel longer-term revenue growth, the Company recorded operating income of $20,173,000, or 23% of revenue, in the second quarter of 2013, compared to operating income of $23,350,000, or 28% of revenue, in the second quarter of 2012. Lower investment income, due to gains recorded on the sale of Euro-denominated securities during the second quarter of 2012 that did not repeat, and a lower effective tax rate resulted in net income of $16,820,000, or 19% of revenue, in the second quarter of 2013, compared to net income of $19,767,000, or 23% of revenue, in the second quarter of 2012. Net income per diluted share was $0.38 in the second quarter of 2013, compared to $0.45 in the second quarter of 2012.
Results of Operations
As foreign currency exchange rates are a factor in understanding period-to-period comparisons, we believe the presentation of results on a constant-currency basis in addition to reported results helps improve investors ability to understand our operating results and evaluate our performance in comparison to prior periods. We also use results on a constant-currency basis as one measure to evaluate our performance. Constant-currency information compares results between periods as if exchange rates had remained constant period-over-period. We generally refer to such amounts calculated on a constant-currency basis as excluding the impact of foreign currency exchange rate changes. Results on a constant-currency basis are not in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and should be considered in addition to, and not as a substitute for, results prepared in accordance with U.S. GAAP.
Revenue
Revenue increased by $2,184,000, or 3%, for the three-month period in 2013 compared to the same period in 2012, and increased by $5,367,000, or 3%, for the six-month period in 2013 compared to the same period in 2012. The increase in revenue for both periods was due to higher sales to factory automation customers, partially offset by lower sales to surface inspection and semiconductor and electronics capital equipment customers.
Factory Automation Market
Sales to customers in the factory automation market represented 78% of total revenue for both the three-month and six-month periods in 2013, respectively, compared to 73% and 75% for the same periods in 2012. Sales to these customers increased by $5,515,000, or 9%, for the three-month period and increased by $9,497,000, or 8%, for the six-month period. A weaker Japanese Yen in 2013 compared to the prior year had
22
Table of Contents
a negative impact on reported factory automation revenue, as sales denominated in Yen were translated to U.S. Dollars at a lower rate. Excluding the impact of foreign currency exchange rate changes on revenue, sales to factory automation customers increased by $6,738,000, or 11%, for the three-month period and increased by $11,277,000, or 9%, for the six-month period.
Geographically, increases for both the three-month and six-month periods were noted across all major regions except for Japan. However, excluding the impact of foreign currency exchange rate changes, the Japanese market was relatively flat compared to both the three-month and six-month periods of 2012. Revenue in Japan had declined in both 2011 and 2012 since the natural disasters that hit this region early in 2011. In both the three-month and six-month periods, the largest percentage increases were noted in Asia where the Company has made significant investments, particularly in China, to expand its sales and support infrastructure in order to access more of the machine vision market in this high-potential growth region. By product line, the largest increase from the prior year in both the three-month and six-month periods came from sales of the Companys ID Products, which are used in manufacturing applications as well as in the logistics industry for package sorting and distribution. The Company expects its Asia region and its ID Products business to provide growth opportunities in the second half of 2013.
Sales to factory automation customers increased by $3,789,000, or 6%, from the first quarter of 2013, with the largest increase coming from Asia. Management expects factory automation revenue to continue to grow in the third quarter as compared to the second quarter despite historical seasonal softness that can impact revenue levels during the summer months.
Semiconductor and Electronics Capital Equipment Market
Sales to customers who make automation equipment for the semiconductor and electronics industries represented 8% of total revenue for both the three-month and six-month periods in 2013, respectively, compared to 12% and 10% for the same periods in 2012. Sales to these customers decreased by $2,723,000, or 28%, for the three-month period and decreased by $2,435,000, or 15%, for the six-month period. Excluding the impact of foreign currency exchange rate changes, which primarily relates to the Japanese Yen, sales to semiconductor and electronics capital equipment customers decreased by $2,305,000, or 24%, for the three-month period and decreased $1,773,000, or 11%, for the six-month period.
Although sales to these customers increased by $113,000, or 2%, from the first quarter of 2013, representing the second sequential quarter of sales growth, the semiconductor and electronics capital equipment market has historically been highly cyclical and management has limited visibility regarding future order levels from these customers.
Surface Inspection Market
Sales to customers in the surface inspection market represented 14% of total revenue for both the three-month and six-month periods in 2013, compared to 15% for both the three-month and six-month periods in 2012. Revenue from these customers decreased by $608,000, or 5%, for the three-month period and decreased by $1,695,000, or 7%, for the six-month period. Excluding the impact of foreign currency exchange rate changes, which primarily relates to the Japanese Yen, sales to surface inspection customers increased by $132,000, or 1%, for the three-month period and decreased by $738,000, or 3%, for the six-month period due to lower product revenue. Revenue from the surface inspection market increased by $1,716,000, or 16%, from the first quarter of 2013. The revenue reported each quarter can vary significantly depending upon the timing of customer orders, system deliveries, and installations, as well as the impact of revenue deferrals. Management expects surface inspection revenue to grow in the second half of 2013 as compared to the first half.
Product Revenue
Product revenue increased by $1,249,000, or 2%, for the three-month period and increased by $4,514,000, or 3%, for the six-month period. These increases were driven by a higher volume of modular vision systems sold than in the prior year, partially offset by a lower average selling price due to the shift in revenue mix to ID Products, which have relatively lower average selling prices. We expect this trend related to ID products to continue throughout 2013. Higher MVSD product revenue was partially offset by lower SISD product revenue.
23
Table of Contents
Service Revenue
Service revenue, which is derived from the sale of maintenance and support, training, consulting, and installation services, increased by $935,000, or 16%, for the three-month period and increased by $853,000, or 7%, for the six-month period. The increases for both periods were primarily due to higher revenue from MVSD consulting services. Service revenue as a percentage of total revenue was 8% for both the three-month and six-month periods of 2013 compared to 7% for both the three-month and six-month periods in 2012.
Gross Margin
Gross margin as a percentage of revenue was 76% for all periods presented.
MVSD Margin
MVSD gross margin as a percentage of revenue was 80% and 79% for the three-month and six-month periods in 2013, respectively, compared to 80% for both the three-month and six-month periods in 2012. In the six-month period, the reduction in margin was due to higher new product introduction costs and higher provisions for warranty and for excess and obsolete inventory, partially offset by improvements in consulting service margins.
SISD Margin
SISD gross margin as a percentage of revenue was 52% and 53% for the three-month and six-month periods in 2013, respectively, compared to 51% and 52% for the same periods in 2012. The increase in SISD margin for the three-month and six-month periods was due to improvements in installation service margins.
Product Margin
Product gross margin as a percentage of revenue was 78% for all periods presented. A reduction in MVSD product margins due to higher new product introduction costs and higher provisions for warranty and for excess and obsolete inventory was offset by a favorable shift in revenue mix to relatively higher-margin MVSD products.
Service Margin
Service gross margin as a percentage of revenue was 52% for both the three-month and six-month periods in 2013, compared to 50% and 47% for the same periods in 2012. The increase in service margin for the three-month and six-month periods was due to improvements in MVSD consulting service margins, as well as improved installation service margins at SISD.
Research, Development, and Engineering Expenses
Research, development, and engineering (RD&E) expenses increased by $1,587,000, or 15%, for the three-month period in 2013 compared to the same period in 2012, and increased by $2,547,000, or 12%, for the six-month period in 2013 compared to the same period in 2012. MVSD RD&E expenses increased by $1,528,000, or 16%, for the three-month period and increased by $2,445,000, or 13%, for the six-month period, while SISD RD&E expenses increased by $59,000, or 6%, for the three-month period and increased by $102,000, or 5%, for the six-month period.
24
Table of Contents
The table below details the $1,528,000 and the $2,445,000 net increases in MVSD RD&E for the three-month and six-month periods, respectively (in thousands):
Three-month Period |
Six-month Period |
|||||||
MVSD RD&E expenses in 2012 |
$ | 9,317 | $ | 18,763 | ||||
Personnel-related costs |
892 | 1,742 | ||||||
Company bonus accruals |
293 | 405 | ||||||
Stock-based compensation expense |
159 | 101 | ||||||
Other |
184 | 197 | ||||||
|
|
|
|
|||||
MVSD RD&E expenses in 2013 |
$ | 10,845 | $ | 21,208 | ||||
|
|
|
|
The increase in MVSD RD&E expenses was primarily due to headcount additions, resulting in higher personnel-related costs, such as salaries and fringe benefits. In addition, the Company recorded higher company bonus accruals and increased stock-based compensation expense due to a higher valuation of stock options granted in the first quarter of 2013.
The increase in SISD RD&E expenses was primarily due to higher spending on materials for new product development ($57,000 in the three-month period and $78,000 in the six-month period).
RD&E expenses as a percentage of revenue were 14% for both the three-month and six-month periods in 2013, compared to 12% and 13% for the three-month and six-month periods in 2012, respectively. We believe that a continued commitment to RD&E activities is essential in order to maintain or achieve product leadership with our existing products and to provide innovative new product offerings. In addition, we consider our ability to accelerate time to market for new products to be critical to our revenue growth. Therefore, we expect to continue to make significant RD&E investments in the future, and we target our RD&E spending to be between 10% and 15% of revenue.
Selling, General, and Administrative Expenses
Selling, general, and administrative (SG&A) expenses increased by $3,173,000, or 11%, for the three-month period in 2013 compared to the same period in 2012, and increased by $4,791,000, or 8%, for the six-month period in 2013 compared to the same period in 2012. MVSD SG&A expenses increased by $2,246,000, or 9%, for the three-month period and increased by $3,588,000, or 7%, for the six-month period, while SISD SG&A expenses increased by $313,000, or 11%, for the three-month period and increased by $466,000, or 8%, for the six-month period. Corporate expenses that are not allocated to either division increased by $614,000, or 20%, for the three-month period and increased by $737,000, or 11%, for the six-month period.
The table below details the $2,246,000 and the $3,588,000 net increases in MVSD SG&A for the three-month and six-month periods, respectively (in thousands):
Three-month Period |
Six-month Period |
|||||||
MVSD SG&A expenses in 2012 |
$ | 24,202 | $ | 48,350 | ||||
Personnel-related costs |
686 | 1,494 | ||||||
Sales commissions |
670 | 823 | ||||||
Depreciation expense |
219 | 484 | ||||||
Company bonus accruals |
281 | 397 | ||||||
Sales demonstration equipment |
160 | 384 | ||||||
Recruiting costs |
226 | 311 | ||||||
Stock-based compensation expense |
188 | 137 | ||||||
Foreign currency exchange rate changes |
(697 | ) | (989 | ) | ||||
Other |
513 | 547 | ||||||
|
|
|
|
|||||
MVSD SG&A expenses in 2013 |
$ | 26,448 | $ | 51,938 | ||||
|
|
|
|
Personnel-related costs have increased from the prior year due to additional headcount, and to a lesser extent, higher average costs per employee. Over the past year, the Company has continued to increase headcount in strategic areas, principally Sales, resulting in higher personnel-related costs, such as salaries, fringe benefits, commissions, and travel expenses. Average costs per employee have increased over the prior year due primarily to modest wage increases granted early in 2013 and higher fringe benefits, such as health care costs. The Company also recorded higher expenses related to sales commissions resulting from higher business levels, depreciation expense related principally to business system upgrades, company bonus accruals, sales demonstration equipment, recruiting costs, and stock-based compensation expense due to a higher stock price valuation for options granted in the first quarter of 2013. These increases were offset by the favorable impact of a weaker Japanese Yen in 2013 compared to the prior year, as expenses denominated in Yen were translated to U.S. Dollars at a lower rate.
25
Table of Contents
The increase in SISD SG&A expenses was primarily due to higher salaries and fringe benefits expenses ($280,000 for the three-month period and $506,000 for the six-month period).
The increase in corporate expenses was primarily related to higher company bonus accruals ($250,000 for the three-month period and $419,000 for the six-month period) and increased stock-based compensation expense due to a higher valuation of stock options granted in the first quarter of 2013 ($358,000 in the three-month period and $434,000 in the six-month period).
Nonoperating Income (Expense)
The Company recorded foreign currency gains of $76,000 and $139,000 for the three-month and six-month periods in 2013, respectively, compared to foreign currency losses of $30,000 and $668,000 for the three-month and six-month periods of 2012, respectively. The foreign currency gains and losses in each period resulted primarily from the revaluation and settlement of accounts receivable and intercompany balances that are reported in one currency and collected in another. Although a portion of the Companys foreign currency exposure of accounts receivable is mitigated through the use of forward contracts, this program depends upon forecasts of sales and collections, and therefore, gains or losses on the underlying receivables may not perfectly offset losses or gains on the contracts.
Investment income decreased by $1,027,000, or 57%, for the three-month period in 2013 compared to the same period in 2012, and decreased by $1,607,000, or 58%, for the six-month period in 2013 compared to the same period in 2012. In the second quarter of 2012, the Company liquidated its Euro-denominated investment portfolio resulting in $1,071,000 of net gains recorded on the sale of these investments. These funds were reinvested in U.S. Dollar-denominated securities during the third quarter of 2013. The remaining decline for the six-month period was primarily due to a $462,000 unrealized loss recorded in current operations on a corporate stock holding designated as a trading security. The majority of this loss was recorded in the first quarter of 2013.
The Company recorded other expense, net of other income, of $257,000 and $140,000 for the three-month and six-month periods in 2013, respectively, compared to other expense of $99,000 and $96,000 for the same periods in 2012. The Company recorded $354,000 and $141,000 of other income in the first quarters of 2013 and 2012, respectively, due to the expiration of the statutes of limitations relating to tax holidays, during which time the Company collected value-added taxes from customers that were not required to be remitted to the government authority. Other income (expense) also includes rental income, net of associated expenses, from leasing buildings adjacent to the Companys corporate headquarters. More of this space was unoccupied in 2013.
Income Tax Expense
The Companys effective tax rate was 19% and 18% for the three-month and six-month periods in 2013, respectively, compared to 21% for both the three-month and six-month periods in 2012. The effective tax rate for the six-month period in 2013 was impacted by one discrete event in the first quarter of 2013 related to the retroactive application of the 2012 R&D credit passed by Congress under the American Taxpayer Relief Act of 2012, which reduced tax expense by $555,000. Although the provisions under this law were made retroactive to January 1, 2012, the law was signed on January 1, 2013, and therefore, the financial impact of any retroactive provision has been recorded as a discrete event in the first quarter of 2013. Excluding this discrete event, the effective tax rate for the six-month period in 2013 was 19%. There were no discrete events in the six-month period in 2012. In addition to the discrete event discussed above, the remaining decrease in the effective tax rate was primarily due to a higher proportion of pre-tax income earned in lower tax jurisdictions.
26
Table of Contents
Liquidity and Capital Resources
The Company has historically been able to generate positive cash flow from operations, which has funded its operating activities and other cash requirements and has resulted in an accumulated cash, cash equivalent, and investment balance of $426,271,000 as of June 30, 2013. The Company has established guidelines relative to credit ratings, diversification, and maturities of its investments that maintain liquidity.
The Companys cash requirements during the six months ended June 30, 2013 were met with its existing cash balances, cash from investment maturities, positive cash flows from operations, and the proceeds from stock option exercises. Cash requirements primarily consisted of operating activities, purchases of investments, the Companys stock repurchase program, and capital expenditures. Capital expenditures for the six months ended July 1, 2012 totaled $4,310,000 and consisted primarily of expenditures for computer hardware and software, as well as manufacturing test equipment related to new product introductions.
The Company is a Limited Partner in Venrock Associates III, L.P. (Venrock), a venture capital fund. The Company has committed to a total investment in the limited partnership of up to $20,500,000, with the commitment period expiring on December 31, 2013. The Company does not have the right to withdraw from the partnership prior to December 31, 2013. As of June 30, 2013, the Company had contributed $19,886,000 to the partnership. The remaining commitment of $614,000 can be called by Venrock in any period through December 31, 2013. Distributions and contributions are at the discretion of Venrocks management. No contributions were made during the six months ended June 30, 2013. The Company received a cash distribution of $1,285,000 during the second quarter of 2013, which was accounted for as a return of capital.
Beginning in the third quarter of 2003, the Companys Board of Directors had declared and paid a cash dividend in each quarter. In December 2012, the Company declared and paid an $0.11 dividend that would normally be declared in the first quarter of 2013 in conjunction with the 2012 earnings release. A special dividend of $1.00 was also declared and paid in the fourth quarter of 2012 to replace expected quarterly dividend declarations for the next eight quarters, beginning in 2013. The additional $0.11 dividend and the $1.00 dividend were accelerated due to the anticipated increase in the federal tax on dividends paid after December 31, 2012. Due to these accelerated payments, no dividends were declared or paid during the six months ended June 30, 2013. Future dividends will be declared at the discretion of the Companys Board of Directors and will depend upon such factors as the Board deems relevant including, among other things, the Companys ability to generate positive cash flows from operations.
In April 2008, the Companys Board of Directors authorized the repurchase of up to $50,000,000 of the Companys common stock, primarily as a means to reduce the dilutive effect of employee stock options. As of June 30, 2013, the Company had repurchased 1,643,875 shares at a cost of $41,891,000 under this program, including 268,000 shares at a cost of $11,891,000 in the second quarter of 2013. In November 2011, the Companys Board of Directors authorized the repurchase of up to $80,000,000 of the Companys common stock to help reduce share dilution associated with equity incentive plans. This new authorization will commence once the Company completes the $50,000,000 program noted above, of which $8,109,000 remains available. The Company may repurchase shares under these programs in future periods depending upon a variety of factors, including, among other things, stock price, share availability, and cash requirements.
The Company believes that its existing cash, cash equivalent, and investment balances, together with cash flow from operations, will be sufficient to meet its operating, investing, and financing activities for the next twelve months. As of June 30, 2013, the Company had approximately $423,816,000 in cash, cash equivalents, debt securities, or equity securities that could be converted into cash. In addition, the Company has no debt and does not anticipate needing debt financing in the near future. We believe that our strong cash position has put us in a relatively good position with respect to our longer-term liquidity needs.
New Pronouncements
Accounting Standards Update (ASU) 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists
The amendments in ASU 2013-11 require companies to present an unrecognized tax benefit, or a portion thereof, as a reduction to a deferred tax asset for a net operating loss (NOL) carryforward or a similar tax loss or tax credit carryforward, unless the uncertain tax position is not available to reduce, or would not be used to reduce, the NOL or carryforward under the tax law in the same jurisdiction; otherwise, the unrecognized tax benefit should be presented as a gross liability and should not net the unrecognized tax benefit with a deferred tax asset. As the Company does not currently have any NOL carryforwards, this guidance will most likely apply to research and development tax credit carryforwards. ASU 2013-11 is effective for annual periods beginning after December 15, 2013 and should be applied to all unrecognized tax benefits that exist as of the effective date. Companies may choose to apply this guidance retrospectively to each prior reporting period presented. Management is the process of evaluating the impact of this Update.
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to the Companys exposures to market risk since December 31, 2012.
27
Table of Contents
ITEM 4: CONTROLS AND PROCEDURES
As required by Rules 13a-15 and 15d-15 of the Securities Exchange Act of 1934, the Company has evaluated, with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, the effectiveness of its disclosure controls and procedures (as defined in such rules) as of the end of the period covered by this report. Based on such evaluation, the Chief Executive Officer and Chief Financial Officer concluded that such disclosure controls and procedures were effective as of that date. From time to time, the Company reviews its disclosure controls and procedures, and may from time to time make changes aimed at enhancing their effectiveness and to ensure that the Companys systems evolve with its business. There was no change in the Companys internal control over financial reporting that occurred during the quarter ended June 30, 2013 that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting.
28
Table of Contents
ITEM 1. | LEGAL PROCEEDINGS |
In May 2008, the Company filed a complaint against MvTec Software GmbH, MvTec LLC, and Fuji America Corporation in the United States District Court for the District of Massachusetts alleging infringement of certain patents owned by the Company. In April 2009 and again in June 2009, Defendant MvTec Software GmbH filed re-examination requests of the patents-at-issue with the United States Patent and Trademark Office. This matter is ongoing.
In May 2009, the Company pre-filed a complaint with the United States International Trade Commission (ITC) pursuant to Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. §1337, against MvTec Software GmbH, MvTec LLC, Fuji America, and several other respondents alleging unfair methods of competition and unfair acts in the unlawful importation into the United States, sale for importation, or sale within the United States after importation. By this filing, the Company requested the ITC to investigate the Companys contention that certain machine vision software, machine vision systems, and products containing the same infringe, and respondents directly infringe and/or actively induce and/or contribute to the infringement in the United States, of one or more of the Companys U.S. patents. In July 2009, the ITC issued an order that it would institute an investigation based upon the Companys assertions. In September 2009, the Company reached a settlement with two of the respondents, and in December 2009, the Company reached a settlement with five additional respondents. In March 2010, the Company reached a settlement with respondent Fuji Machine Manufacturing Co., Ltd. and its subsidiary Fuji America Corporation. These settlements did not have a material impact on the Companys financial results. An ITC hearing was held in May 2010. In July 2010, the Administrative Law Judge issued an initial determination finding two of the Companys patents invalid and that respondents did not infringe the patents-at-issue. In September 2010, the ITC issued a notice that it would review the initial determination of the Administrative Law Judge. The ITC issued its Final Determination in November 2010 in which it determined to modify-in-part and affirm-in-part the Administrative Law Judges determination, and terminate the investigation with a finding of no violation of Section 337 of the Tariff Act of 1930 (as amended 19 U.S.C. §1337). The Company has filed an appeal of the decision with the United States Court of Appeals for the Federal Circuit. An oral hearing before the United States Court of Appeals occurred in February 2012. This matter is ongoing.
In March 2013, the Company filed a lawsuit against Microscan Systems, Inc. (Microscan) and Code Corporation in the United States District Court for the Southern District of New York alleging that Microscans Mobile Hawk handheld imager infringes U.S. Patent 7,874,487 owned by the Company. The lawsuit seeks to prohibit Code Corporation from manufacturing the product, and Microscan from selling and distributing the product. The Company is also seeking monetary damages resulting from the alleged infringement. In April 2013, Microscan filed ex parte re-examination requests of the patent-at-issue with the United States Patent and Trademark Office. These matters are ongoing.
The Company cannot predict the outcome of the above-referenced pending matters and an adverse resolution of these lawsuits could have a material adverse effect on the Companys financial position, liquidity, results of operations, and/or indemnification obligations. In addition, various other claims and legal proceedings generally incidental to the normal course of business are pending or threatened on behalf of or against the Company. While we cannot predict the outcome of these incidental matters, we believe that any liability arising from them will not have a material adverse effect on our financial position, liquidity, or results of operations.
29
Table of Contents
ITEM 1A. | RISK FACTORS |
For a complete list of factors that could affect the Companys business, results of operations, and financial condition, see the risk factors discussion provided in Part I Item 1A of the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS |
The following table sets forth information with respect to purchases by the Company of shares of its Common Stock during the periods indicated.
Total Number of Shares Purchased |
Average Price Paid per Share |
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) |
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs |
|||||||||||||
April 1 - April 28, 2013 |
| | | $ | 100,000,000 | |||||||||||
April 29 - May 26, 2013 |
81,000 | 43.22 | 81,000 | $ | 96,499,000 | |||||||||||
May 27 - June 30, 2013 |
187,000 | 44.88 | 187,000 | $ | 88,109,000 | |||||||||||
|
|
|
|
|
|
|||||||||||
Total |
268,000 | 44.38 | 268,000 | $ | 88,109,000 |
(1) | In April 2008, the Companys Board of Directors authorized the repurchase of up to $50,000,000 of the Companys common stock. In November 2011, the Companys Board of Directors authorized the repurchase of up to an additional $80,000,000 of the Companys common stock to commence once the Company completes the $50,000,000 program noted above. |
30
Table of Contents
ITEM 3. | DEFAULTS UPON SENIOR SECURITIES |
None
ITEM 4. | MINE SAFETY DISCLOSURES |
Not applicable.
ITEM 5. | OTHER INFORMATION |
None
ITEM 6. | EXHIBITS |
31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934*
31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934*
32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
101 xBRL (Extensible Business Reporting Language)***
The following materials from Cognex Corporations Quarterly Report on Form 10-Q for the period ended June 30, 2013, formatted in xBRL: (i) Consolidated Statements of Operations for the three-month and six-month periods ended June 30, 2013 and July 1, 2012; (ii) Consolidated Statements of Comprehensive Income for the three-month and six-month periods ended June 30, 2013 and July 1, 2012; (iii) Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012; (iv) Consolidated Statement of Shareholders Equity for the six-month period ended June 30, 2013; (v) Consolidated Condensed Statements of Cash Flows for the six-month periods ended June 30, 2013 and July 1, 2012; and (vi) Notes to Consolidated Financial Statements.
* | Filed herewith |
** | Furnished herewith |
*** | Pursuant to Rule 406T of Regulation S-T, the xBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934. |
31
Table of Contents
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: July 29, 2013 | COGNEX CORPORATION | |||||
By: | /s/ Robert J. Willett | |||||
Robert J. Willett | ||||||
President and Chief Executive Officer | ||||||
(principal executive officer) | ||||||
By: | /s/ Richard A. Morin | |||||
Richard A. Morin | ||||||
Executive Vice President of Finance and Administration | ||||||
and Chief Financial Officer | ||||||
(principal financial and accounting officer) |
32